The Pediatric Cancer Center Barcelona (PCCB) at Hospital Sant Joan de Déu has become the first center outside North America to join the Beat Childhood Cancer (BCC) Research Consortium, a pediatric cancer research organization that, until now, included only institutions from the United States and Canada.
The new partnership enables Penn State College of Medicine and the BCC Research Consortium to expand its pediatric cancer clinical trials into Europe, marking a major milestone in the effort to accelerate access to life-saving therapies for children worldwide.
The BCC Research Consortium is dedicated to developing clinical trials for pediatric cancers in collaboration with emerging pharmaceutical companies that are creating new treatments. While trials in the United States are promoted directly by the consortium, the PCCB will assume the role of European sponsor. The PCCB has a highly specialized team and facilities that integrate clinical care services with dedicated research spaces that will make it a valuable addition to the Consortium.
These projects are supported by Four Diamonds, the Beat Childhood Cancer Foundation, and a network of philanthropic organizations powered by fundraising efforts led by families and communities affected by pediatric cancer.
